Epratuzumab, New Drug In Development For Systemic Lupus Erythamatosus Enters Phase III Trials After Promising Results In A Smaller Study
Links shared publicly online about this topic.
- 725total visits
Epratuzumab, New Drug In Development For Systemic Lupus Erythamatosus Enters Phase III Trials After Promising Results In A Smaller Study
For the past 50 years there have been no new drug treatments approved for systemic lupus erythamatosus (SLE). Now, at last, that situation could soon change. The FDA is currently reviewing one ne
View full resource at medicalnewstoday.com
Tags: Lupus, Systemic Lupus Erythematosus, Drug, FDA
Most Recently Shared on November 15, 2010 at 6:05 pm By:
Epratuzumab, New Drug In Development For Systemic Lupus Erythamatosus Enters Phase III Trials After Promising Results ... http://mnt.to/3MCd
Also Shared By:
Advertisement
Health Line
@LupusLine
Epratuzumab, New Drug In Development For Systemic Lupus Erythamatosus Enters Phase III Trials After Promising Resul... http://sns.ly/dtW62
1 year ago...